we are nemagen discoveries

NemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases.

Our Science

NemaGen's novel technologies were developed by investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. By taking this unique approach NemaGen has pioneered new therapeutic strategies to help patients suffering from diverse inflammatory diseases.

Latest News

NemaGen has received a Phase I SBIR from NCATS

NemaGen is honored and excited to announce that we were awarded an NIH Small Business Innovation Research grant. We would like to thank the NIH and NCATS for recognizing the significance and impact of our work focused on treating mastocytosis and other mast cell-related diseases.

Read the grant

Connect with us

Contact Us

Please email us for more information regarding our novel technologies or exciting employment opportunities.

mark.siracusa@nemagen.com

Powered by GoDaddy Website Builder